226 related articles for article (PubMed ID: 18076548)
1. Sleeping hearts: the role of the heart in sleeping sickness (human African trypanosomiasis).
Blum JA; Burri C; Hatz C; Kazumba L; Mangoni P; Zellweger MJ
Trop Med Int Health; 2007 Dec; 12(12):1422-32. PubMed ID: 18076548
[TBL] [Abstract][Full Text] [Related]
2. Sleeping glands? - The role of endocrine disorders in sleeping sickness (T.b. gambiense Human African Trypanosomiasis).
Blum JA; Schmid C; Hatz C; Kazumba L; Mangoni P; Rutishauser J; la Torre A; Burri C
Acta Trop; 2007 Oct; 104(1):16-24. PubMed ID: 17767911
[TBL] [Abstract][Full Text] [Related]
3. Clinical presentation and treatment outcome of sleeping sickness in Sudanese pre-school children.
Eperon G; Schmid C; Loutan L; Chappuis F
Acta Trop; 2007 Jan; 101(1):31-9. PubMed ID: 17207760
[TBL] [Abstract][Full Text] [Related]
4. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.
Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U
Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225
[TBL] [Abstract][Full Text] [Related]
5. Novel markers for treatment outcome in late-stage Trypanosoma brucei gambiense trypanosomiasis.
Lejon V; Roger I; Mumba Ngoyi D; Menten J; Robays J; N'siesi FX; Bisser S; Boelaert M; Büscher P
Clin Infect Dis; 2008 Jul; 47(1):15-22. PubMed ID: 18494605
[TBL] [Abstract][Full Text] [Related]
6. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
Chappuis F; Udayraj N; Stietenroth K; Meussen A; Bovier PA
Clin Infect Dis; 2005 Sep; 41(5):748-51. PubMed ID: 16080099
[TBL] [Abstract][Full Text] [Related]
7. Sleep structure: a new diagnostic tool for stage determination in sleeping sickness.
Buguet A; Bisser S; Josenando T; Chapotot F; Cespuglio R
Acta Trop; 2005 Jan; 93(1):107-17. PubMed ID: 15589803
[TBL] [Abstract][Full Text] [Related]
8. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.
Bisser S; N'Siesi FX; Lejon V; Preux PM; Van Nieuwenhove S; Miaka Mia Bilenge C; Būscher P
J Infect Dis; 2007 Feb; 195(3):322-9. PubMed ID: 17205469
[TBL] [Abstract][Full Text] [Related]
9. [A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo].
Eozenou P; Jannin J; Ngampo S; Carme B; Tell GP; Schechter PJ
Med Trop (Mars); 1989; 49(2):149-54. PubMed ID: 2507863
[TBL] [Abstract][Full Text] [Related]
10. Eflornithine for the treatment of human African trypanosomiasis.
Burri C; Brun R
Parasitol Res; 2003 Jun; 90 Supp 1():S49-52. PubMed ID: 12811548
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes.
Balasegaram M; Young H; Chappuis F; Priotto G; Raguenaud ME; Checchi F
Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):280-90. PubMed ID: 18947846
[TBL] [Abstract][Full Text] [Related]
12. Current chemotherapy of human African trypanosomiasis.
Docampo R; Moreno SN
Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
[TBL] [Abstract][Full Text] [Related]
13. Human African trypanosomiasis in Angola: clinical observations, treatment, and use of PCR for stage determination of early stage of the disease.
Truc P; Lando A; Penchenier L; Vatunga G; Josenando T
Trans R Soc Trop Med Hyg; 2012 Jan; 106(1):10-4. PubMed ID: 22093811
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II).
Schmid C; Richer M; Bilenge CM; Josenando T; Chappuis F; Manthelot CR; Nangouma A; Doua F; Asumu PN; Simarro PP; Burri C
J Infect Dis; 2005 Jun; 191(11):1922-31. PubMed ID: 15871127
[TBL] [Abstract][Full Text] [Related]
15. [Electroencephalographic study of trypanosomes in meningoencephalitic stage of human African trypanosomiasis from Trypanosoma brucei gambiense before and after treatment with DL-alphadifluoromethyl- ornithine hydrochloride monohydrate (DFMO)].
Hamon JF; Camara P
Bull Soc Pathol Exot; 1992; 85(5):378-84. PubMed ID: 1292798
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic failure of melarsoprol among patients treated for late stage T.b. gambiense human African trypanosomiasis in Uganda].
Legros D; Fournier C; Gastellu Etchegorry M; Maiso F; Szumilin E
Bull Soc Pathol Exot; 1999 Jul; 92(3):171-2. PubMed ID: 10472443
[TBL] [Abstract][Full Text] [Related]
17. Randomized, controlled trial of treatments for second-stage sleeping sickness.
Woodrow CJ; Abel PM; Krishna S
J Infect Dis; 2007 Aug; 196(4):650-1. PubMed ID: 17624857
[No Abstract] [Full Text] [Related]
18. [Human African trypanosomiasis in Ivory Coast: biological characteristics after treatment. 812 cases treated in the Daloa focus (Ivory Coast)].
Miezan TW; Dje NN; Doua F; Boa F
Bull Soc Pathol Exot; 2002 Dec; 95(5):362-5. PubMed ID: 12696377
[TBL] [Abstract][Full Text] [Related]
19. [Three patients with African sleeping sickness following a visit to Tanzania].
Mendonça Melo M; Rasica M; van Thiel PP; Richter C; Kager PA; Wismans PJ
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2552-6. PubMed ID: 12532670
[TBL] [Abstract][Full Text] [Related]
20. [The return of sleeping sickness in an epidemic form: international action for drugs].
Kager PA
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2527-30. PubMed ID: 12532663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]